ACLX logo

ACLX
Arcellx Inc

514
Mkt Cap
$6.71B
Volume
469,629.00
52W High
$114.94
52W Low
$47.86
PE Ratio
-28.31
ACLX Fundamentals
Price
$114.80
Prev Close
$114.79
Open
$114.78
50D MA
$98.74
Beta
1.01
Avg. Volume
1.47M
EPS (Annual)
-$4.07
P/B
16.53
Rev/Employee
$106,631.58
$3,272.71
Loading...
Loading...
News
all
press releases
60,364 Shares in Arcellx, Inc. $ACLX Purchased by Aberdeen Group plc
Aberdeen Group plc purchased a new position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom
Gilead Sciences (NASDAQ:GILD) executives on Tuesday outlined the company's rationale for three recently announced transactions its proposed acquisitions of Tubulis, Ouro Medicines, and Arcellx...
MarketBeat·2d ago
News Placeholder
Arcellx (NASDAQ:ACLX) Reaches New 12-Month High - Here's What Happened
Arcellx (NASDAQ:ACLX) Sets New 52-Week High - Time to Buy...
MarketBeat·9d ago
News Placeholder
Arcellx, Inc. (NASDAQ:ACLX) Given Average Recommendation of "Hold" by Brokerages
Shares of Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) have been given a consensus rating of "Hold" by the nineteen research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, sixteen have given a hold recommendation, on...
MarketBeat·11d ago
News Placeholder
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology platforms.
Zacks·17d ago
News Placeholder
Arcellx (NASDAQ:ACLX) Upgraded by Truist Financial to Strong-Buy Rating
Truist Financial raised Arcellx from a "hold" rating to a "strong-buy" rating in a report on Friday...
MarketBeat·20d ago
News Placeholder
Arcellx (NASDAQ:ACLX) Sets New 52-Week High - Here's What Happened
Arcellx (NASDAQ:ACLX) Hits New 12-Month High - Here's What Happened...
MarketBeat·20d ago
News Placeholder
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders? Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 19, 2026 Insiders may stand to receive...
PR Newswire·22d ago
News Placeholder
JPMorgan Chase & Co. Decreases Holdings in Arcellx, Inc. $ACLX
JPMorgan Chase & Co. reduced its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 9.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 882,503 shares of the company's stock after selling 94,465 shar...
MarketBeat·22d ago
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR...
PR Newswire·23d ago
<
1
2
...
>

Latest ACLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.